Farxiga is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.
Fycompa is indicated to treat partial-onset seizures in patients aged 12 years and older.
Sofosbuvir is indicated for use with other medications as part of an antiviral treatment regimen for chronic hepatitis C infection.
Opsumit is indicated for treatment of pulmonary arterial hypertension to delay disease progression.
Adempas is indicated for persistent/recurrent chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension.
Results from four clinical trials in adults show Picato topical gel helps clear actinic keratosis on the face, scalp, trunk and extremities.
Jentadueto is an oral formulation of linagliptin and metformin indicated as an adjunct therapy to diet and exercise for treating type 2 diabetes.
Fentanyl nasal spray is indicated for breakthrough pain in opioid-tolerant patients who are already receiving and tolerant to continuous opioid therapy for underlying persistent cancer pain.
Complera is a fixed-dose combination of the antiviral drugs emtricitabine, rilpivirine and tenofovir disoproxil fumarate.
Solesta is a biocompatible tissue-bulking agent, consisting of dextranomer microspheres and stabilized sodium hyaluronate. While
Want to read more?
Please login or register first to view this content.
Next post in Drug Update